Biosenic (CHIX:BIOSB) Payments of Debt: €-0.25 Mil (TTM As of Dec. 2024)


CHIX:BIOSB Biosenic CHIX:BIOSB
9 GF Score
Price €2.60
View Full Analysis

What is Biosenic Payments of Debt?

Biosenic CHIX:BIOSB 9 Payments of Debt is €-0.25 Mil as of Dec. 2024. GuruFocus rates CHIX:BIOSB with a GF Score™ of 9/100.

Biosenic's Payments of Debt for the six months ended in Dec. 2024 was €-0.13 Mil.

Biosenic's Payments of Debt for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.25 Mil.

Biosenic Payments of Debt Related Terms

Biosenic Payments of Debt Historical Data

* Premium members only.

The historical data trend for Biosenic's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biosenic Payments of Debt Chart

Biosenic Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.61 -0.18 -0.42 -0.41 -0.25

Biosenic Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.38 -0.15 -0.26 -0.12 -0.13
CHIX:BIOSB
9GF Score
Biosenic CHIX:BIOSB
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biosenic Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.25 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of €-0.25 Mil mean?
Biosenic (CHIX:BIOSB) has a Payments of Debt of €-0.25 Mil as of Dec. 2024. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Biosenic and its competitors.
Is Biosenic's Payments of Debt too high?
Biosenic's current Payments of Debt is €-0.25 Mil. Overall, Biosenic has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Biosenic's Payments of Debt compare to VRTX and REGN?
Biosenic's Payments of Debt of €-0.25 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Biotechnology company?
A good Payments of Debt depends on the Biotechnology industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Biosenic and its competitors. Biosenic's current Payments of Debt is €-0.25 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biosenic stock overvalued right now?
Biosenic (CHIX:BIOSB) has a current Payments of Debt of €-0.25 Mil. The current Payments of Debt is €-0.25 Mil. Biosenic's overall GF Score™ is 9/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Biosenic (CHIX:BIOSB), the current Payments of Debt is €-0.25 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biosenic Business Description

Address Rue Granbonpre 11, Batiment H (bte 24), Mont-St-Guibert, BEL, 1435
Biosenic is engaged in the development of cell therapy products for orthopaedics and bone diseases. The product pipeline of the company includes; ALLOB for treatment of delayed-union fractures, spinal fusion procedures and revision spinal fusion, and PREOB. In addition, the firm is also focused on conducting preclinical research on next-generation product candidates such as combined cell-matrix products for large bone defects and maxillofacial applications.
9GF Score

Get the complete analysis for CHIX:BIOSB

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.60
Price